Publications by authors named "Meaghan Gibbs"

Claim this Profile
A
A cost-effectiveness analysis model of actionable genomic alteration testing strategies incorporating different modalities and sizes of next-generation sequencing panels in non-small-cell lung cancer.
Yvonne L E Ang, Jian Chun Matthew Ong, Yiqing Huang, Jia Li Low, Kenneth Sooi, Meaghan Gibbs

Ther Adv Med Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Economic Impact of Upfront Next-Generation Sequencing for Metastatic NSCLC in East Asia.
Herbert H Loong, Carlos K H Wong, Catherine P K Chan, Andrea Chang, Zheng-Yi Zhou, Meaghan Gibbs

JTO Clin Res Rep· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis of ceritinib vs. crizotinib in previously untreated anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) in Hong Kong.
Herbert H Loong, Carlos K H Wong, Linda K S Leung, Catherine P K Chan, Andrea Chang, Meaghan Gibbs

Cost Eff Resour Alloc· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilities for Type 2 Diabetes Treatment-Related Attributes in a South Korean and Taiwanese Population.
Narayan Rajan, Kristina S Boye, Meaghan Gibbs, Yoon Ji Lee, Peter Davey

Value Health Reg Issues· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of switching to biphasic insulin aspart in poorly-controlled type 2 diabetes patients in China.
James L Palmer, Meaghan Gibbs, Huib W K F H Scheijbeler, Robert W Kotchie, Steffen Nielsen

Adv Ther· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis